Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 28, 2014; 20(28): 9286-9291
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9286
Figure 1
Figure 1 Local-regional treatment failure with colorectal cancer resection may present as local recurrence and/or peritoneal metastases. Free cancer cells or tiny nodules disseminated from the primary cancer may implant and grow at high density at the resection site as a local recurrence. Low density cancer implants at a distance will become peritoneal metastases.
Figure 2
Figure 2 Two ways to enter the proactive management clinical pathway. HIPEC: Hyperthermic perioperative chemotherapy; FOLFOX: Folinic acid, 5-fluorouracil, and oxaliplatin.
Figure 3
Figure 3 Hazard ratios and multilevel confidence intervals for prognostic factors of survival in patients with peritoneal carcinomatosis of colorectal origin treated by CRS and hyperthermic perioperative chemotherapy[7]. HR: Hazard ratio.